Original Article
Use of Cerebrospinal Fluid Flow Rates Measured by Phase-Contrast MR to Predict Outcome of Ventriculoperitoneal Shunting for Idiopathic Normal-Pressure Hydrocephalus

https://doi.org/10.4065/77.6.509Get rights and content

Objective

To determine whether favorable clinical response and magnitude of improvement are associated with increased aqueductal cerebrospinal fluid (CSF) flow rates in patients who undergo ventriculoperitoneal shunting (VPS) for idiopathic normal-pressure hydrocephalus (NPH).

Patients and Methods

Between January 1995 and June 2000, 49 patients (14 men and 35 women; mean age, 72.9 years; range, 54-88 years) underwent magnetic resonance quantification of aqueductal CSF flow followed by VPS for presumed idiopathic NPH at the Mayo Clinic, Rochester, Minn. Logistic regression models for the odds of any improvement in score as a function of aqueductal CSF flow and separate models for any improvement in gait, incontinence, cognition, and total score were constructed.

Results

Forty-two patients (86%) had improvement in gait at postoperative follow-up (mean, 10 months). Of the 32 patients with incontinence, 27 (69%) improved. Of the 36 patients with cognitive impairment, 16 (44%) improved. In univariate and fully adjusted models, increased CSF flow through the aqueduct was not significantly associated with improvement or the magnitude of improvement in gait, cognition, or incontinence. Thirty-six patients underwent high-volume lumbar puncture preoperatively, of whom 5 (14%) had no response. The aqueductal CSF flow rates of these 5 patients were significantly higher than those of the patients who improved after lumbar puncture. Postoperative complications occurred in 15 patients. The aqueductal CSF flow rates in these 15 patients were not significantly different from those of patients who experienced no complications.

Conclusion

Among patients who underwent VPS for the treatment of NPH, measurement of CSF flow through the cerebral aqueduct did not reliably predict which patients would improve after shunting or the magnitude of improvement.

Section snippets

Clinical Material

The medical records of all patients who underwent VPS for NPH between January 1995 and June 2000 at the Mayo Clinic, Rochester, Minn, were reviewed. Patients without cine phase-contrast MR measurement of aqueductal CSF flow before VPS were excluded from analysis (32 patients during the study period). Seven patients had less than 1 month of postoperative follow-up and therefore were not analyzed. Patients with communicating hydrocephalus due to prior neurologic illness, such as subarachnoid

RESULTS

Postoperative improvement in each symptom category is shown in Table 3. With respect to gait, 42 patients (86%) improved, 6 patients (12%) had no change, and 1 patient (2%) worsened from moderate to severe gait impairment. Improvement in incontinence or cognition was less consistent. Of the 39 patients with incontinence, 27 (69%) were improved, 11 (28%) were unchanged, and 1 (3%) had worsened from moderate to severe incontinence. Of the 36 patients with cognitive impairment, 16 (44%) were

Predicting Outcome of VPS for NPH

Previously, we established that aqueductal CSF flow rate as measured by cine phase-contrast MR was substantially elevated in patients with idiopathic NPH compared with patients with other forms of dementia and healthy elderly controls.13 However, in the present study, we were unable to show a statistically significant association between CSF flow rate and outcome after VPS for NPH. This combination of findings suggests that, although phase-contrast MR measurement of aqueductal CSF flow may be

CONCLUSION

Among patients who underwent VPS for the treatment of NPH, measurement of CSF flow through the cerebral aqueduct did not reliably predict which patients improved after shunting or the magnitude of improvement. However, MR quantification of aqueductal CSF flow may have a role in selecting patients for VPS in whom the diagnosis is uncertain on clinical grounds alone.

Acknowledgments

We are indebted to Mary M. Soper for expert assistance in manuscript preparation.

REFERENCES (22)

  • DW Dippel et al.

    Probabilistic diagnosis of normal pressure hydrocephalus and other treatable cerebral lesions in dementia

    J Neurol Sci

    (1993)
  • RD Adams et al.

    Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure: a treatable syndrome

    N Engl J Med

    (1965)
  • S Hakim

    Algunas observaciones sobre la presion del LCR sindrome hidrocefalio en el adulto con “presion normal” del LCR [thesis]

    (1964)
  • JO Greenberg et al.

    Idiopathic normal pressure hydrocephalus—a report of 73 patients

    J Neurol Neurosurg Psychiatry

    (1977)
  • K Tanaka et al.

    Idiopathic normal pressure hydrocephalus in elderly patients: its pathophysiology and diagnosis [in Japanese]

    No Shinkei Geka

    (1993)
  • J Valk

    Clinical and neuropsychological symptoms of normal pressure hydrocephalus [letter] [in Dutch]

    Ned Tijdschr Geneeskd

    (1987)
  • PM Black et al.

    CSF shunts for dementia, incontinence, and gait disturbance

    Clin Neurosurg

    (1985)
  • RA Hurley et al.

    Normal pressure hydrocephalus: significance of MRI in a potentially treatable dementia

    J Neuropsychiatry Clin Neurosci

    (1999)
  • ER Laws et al.

    Occult hydrocephalus: results of shunting correlated with diagnostic tests

    Clin Neurosurg

    (1977)
  • RC Petersen et al.

    Surgical treatment of idiopathic hydrocephalus in elderly patients

    Neurology

    (1985)
  • P Gideon et al.

    Cerebrospinal fluid flow and production in patients with normal pressure hydrocephalus studied by MRI

    Neuroradiology

    (1994)
  • Cited by (101)

    • Accuracy of MRI derived cerebral aqueduct flow parameters in the diagnosis of idiopathic normal pressure hydrocephalus

      2022, Journal of Clinical Neuroscience
      Citation Excerpt :

      Since then, the clinical utility of PC-MRI derived CSF flow measurements has been a topic of continued research. Hyperdynamic CSF flow through the cerebral aqueduct in iNPH patients has been observed in multiple studies [14,17,21,25], although the predictive power of various CSF flow parameters for diagnosis and prediction of shunting response in iNPH patients are variable across different studies [18,20,22,23,31]. Since there are currently no large-scale studies establishing a set of cut-off values for iNPH diagnosis, CSF flow studies have yet to be included in international clinical guidelines [2,32].

    • Communicating chronic hydrocephalus: A review

      2021, Revue de Medecine Interne
    • Aqueductal Cerebrospinal Fluid Stroke Volume Flow in a Rodent Model of Chronic Communicating Hydrocephalus: Establishing a Homogeneous Study Population for Cerebrospinal Fluid Dynamics Exploration

      2019, World Neurosurgery
      Citation Excerpt :

      Some human studies9,14-27 have shown an important correlation between aqueductal CSF hyperdynamism and shunt responsiveness. Other studies28-30 have obtained different observations, concluding ASV as a poor prognostic marker to shunt outcomes. This discrepancy is preventing the acceptance of ASV as a predictor.

    View all citing articles on Scopus
    View full text